Literature DB >> 22507315

IL-37 (IL-1F7) the newest anti-inflammatory cytokine which suppresses immune responses and inflammation.

S Tete, D Tripodi, M Rosati, F Conti, G Maccauro, A Saggini, E Cianchetti, A Caraffa, P Antinolfi, E Toniato, M L Castellani, P Conti, T C Theoharides.   

Abstract

Cytokines such as interleukins, chemokines and interferons are immunomodulating and inflammatory agents, characterized by considerable redundancy, in that many cytokines appear to share similar functions. Virtually all nucleated cells, but especially epithelial cells and macrophages, are potent producers of cytokines. The objective of this study is to review the detailed mechanism of action and the biological profiles of IL-37, the newest anti-inflammatory cytokine. This review focuses on IL-37, a key cytokine in regulating inflammatory responses, mainly by inhibiting the expression, production and function of proinflammatory cytokines: IL-1 family pro-inflammatory effects are markedly suppressed by IL-37.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22507315     DOI: 10.1177/039463201202500105

Source DB:  PubMed          Journal:  Int J Immunopathol Pharmacol        ISSN: 0394-6320            Impact factor:   3.219


  26 in total

1.  IL-37 mediates the antitumor activity in renal cell carcinoma.

Authors:  Yazhuo Jiang; Yili Wang; Liang Liang; Yang Gao; Juan Chen; Yi Sun; Yongyi Cheng; Yonggang Xu
Journal:  Med Oncol       Date:  2015-10-13       Impact factor: 3.064

2.  The effect of laparoscopic and open surgery on oxidative DNA damage and IL-37 in children with acute appendicitis.

Authors:  Kemal Ayengin; Hamit Hakan Alp; Veli Avci; Zübeyir Huyut
Journal:  Ir J Med Sci       Date:  2020-07-17       Impact factor: 1.568

3.  Effects of interleukin-37 on cardiac function after myocardial infarction in mice.

Authors:  Daoying Xu; Aiqin Wang; Fengqin Jiang; Junhong Hu; Xiuzhou Zhang
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01

Review 4.  Biology of interleukin-37 and its role in autoimmune diseases (Review).

Authors:  Huiqiong Zeng; Kaixia Zhou; Zhizhong Ye
Journal:  Exp Ther Med       Date:  2022-06-07       Impact factor: 2.751

5.  Interleukin-37 ameliorates myocardial ischaemia/reperfusion injury in mice.

Authors:  B Wu; K Meng; Q Ji; M Cheng; K Yu; X Zhao; H Tony; Y Liu; Y Zhou; C Chang; Y Zhong; Z Zhu; W Zhang; X Mao; Q Zeng
Journal:  Clin Exp Immunol       Date:  2014-06       Impact factor: 4.330

6.  Tuberculosis-sensitized monocytes sustain immune response of interleukin-37.

Authors:  Jun-Ai Zhang; Gan-Bin Liu; Bi-Ying Zheng; Yuan-Bin Lu; Yu-Chi Gao; Xiao-Zhen Cai; You-Chao Dai; Shi-Yan Yu; Yan Jia; Chen Chen; Ze-Gang Zhuang; Xin Wang; Wan-Dang Wang; Xiao-Xia Fu; Lai-Long Yi; Ling Shen; Zheng W Chen; Jun-Fa Xu
Journal:  Mol Immunol       Date:  2016-09-29       Impact factor: 4.407

Review 7.  STAT3 inhibitors: finding a home in lymphoma and leukemia.

Authors:  Javier Munoz; Navjot Dhillon; Filip Janku; Stephanie S Watowich; David S Hong
Journal:  Oncologist       Date:  2014-04-04

8.  Production of functional human interleukin 37 using plants.

Authors:  Nadiyah Alqazlan; Hong Diao; Anthony M Jevnikar; Shengwu Ma
Journal:  Plant Cell Rep       Date:  2019-01-18       Impact factor: 4.570

9.  The evaluation of plasma and leukocytic IL-37 expression in early inflammation in patients with acute ST-segment elevation myocardial infarction after PCI.

Authors:  Xin Wang; Xiangna Cai; Lan Chen; Duanmin Xu; Jilin Li
Journal:  Mediators Inflamm       Date:  2015-04-16       Impact factor: 4.711

10.  Elevated levels of cerebrospinal fluid and plasma interleukin-37 in patients with Guillain-Barré syndrome.

Authors:  Cong Li; Pingwei Zhao; Xiguang Sun; Yuanyuan Che; Yanfang Jiang
Journal:  Mediators Inflamm       Date:  2013-09-19       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.